Trials / Unknown
UnknownNCT05456152
Safety and Efficacy of Zolpidem in the Long-Term Treatment of Insomnia
National, Multicenter, Open, Single-arm, Phase III Clinical Trial to Evaluate the Safety and Efficacy of Zolpidem in the Long-Term Treatment of Insomnia.
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 358 (estimated)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of sublingual zolpidem during the long-term treatment of insomnia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sublingual Tablet | Sublingual zolpidem - 1 sublingual tablet 30 minutes before bed time. |
Timeline
- Start date
- 2024-06-01
- Primary completion
- 2025-01-01
- Completion
- 2025-02-01
- First posted
- 2022-07-13
- Last updated
- 2023-09-07
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05456152. Inclusion in this directory is not an endorsement.